Adjuvant chemotherapy for localised colon cancer

Prescrire International

Volumn 20, Issue 113, 2011, Pages 46-49

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; OXALIPLATIN; RALTITREXED; TEGAFUR; URACIL;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER FATIGUE; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; INFECTION; LIMB DYSESTHESIA; LYMPH NODE METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOEMBOLISM; TREATMENT RESPONSE; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; NEOPLASM STAGING; SURVIVAL RATE;

EID: 79851502506     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Prescrire Editorial Staff "Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases" Prescrire Int 2006; 15 (83): 109-111.
2. Prescrire Rédaction "Chimiothérapie du cancer colorectal métastasé". Fluorouracil + acide folinique, oxaliplatin, irinotecan, combinés selon les situations" Rev Prescrire 2010; 30 (320): 438-443.
3. Quasar Collaborative Group "Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study" Lancet 2007; 370: 2020-2029.
4. Figueredo A et al. "Adjuvant therapy for completely resected stage II Colon cancer" (Cochrane review) (2008 update). In: "The Cochrane Database of Systematic Review" John Wiley and Sons, Chichester 2008, issue 3: 102 pages.
5. 5- André T et al. "Phase III study comparing a semi-monthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of Gercor C96.1" J Clin Oncol 2007; 25: 3732-3738. (Pubitemid 47372615)
6. 6- Nordlinger B et al. "Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial" Lancet Oncol 2005; 6 (7): 459-468. (Pubitemid 40903626)
7. Prescrire Rédaction "Capecitabine: adjuvant treatment of colon cancer: oral administration for some patients" Prescrire Int 2006; 15 (83): 102.
8. Prescrire Rédaction "1-3-5-2. Profil d'effets indésirables du tégafur + uracil et de la capé citabine" Rev Prescrire 2010; 30 (326 suppl. interactions médicamenteuses).
9. 9- Lembersky BC et al. "Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06" J Clin Oncol 2006; 24 (13): 2059-2064. (Pubitemid 46622115)
10. Popov I et al. "Raltitrexed (Tomudex°) versus standard leucovorin-modulated bolus 5-fluorouracil: results from the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (Petacc-1)" Eur J Cancer 2008; 44 (15): 2204-2211.
11. Prescrire Rédaction "Oxaliplatin: adjuvant treatment of colon cancer: more data needed" Prescrire Int 2006; 15 (84): 134.
12. André T et al. "Improved survival with oxaliplatin, fluorouracil and leucovorin as adjuvant treatment in stage II or III colon cancer in the Mosaic trial" J Clin Oncol 2009; 27 (19): 3109-3116.
13. 13- Kuebler JP et al. "Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07" J Clin Oncol 2007; 25 (16): 2198-2204. (Pubitemid 46954643)
14. Wolmark N et al. "A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: survival results of NSABP protocol C-07" J Clin Oncol 2008; 26 (20 suppl.): 4005 (abstr.).
15. Prescrire Editorial Staff "Effects of cancer drugs on survival: often poorly evaluated" Prescrire Int 2009; 18 (102): 180-183.
16. 16- Saltz LB et al. "Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803" J Clin Oncol 2007; 25 (23): 3456-3461. (Pubitemid 47310883)
17. Van Custem E et al. "Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: Petacc 3" J Clin Oncol 2009; 27 (19): 3112-3125.
18. Ychou M et al. "A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC accord02/FFCD9802)" Ann Oncol 2009; 20 (4): 674-680.
19. European Commission "SPC- Xeloda" 23 March 2010: 51 pages.